Transcriptional activation of tyrosinase and TRP-I by links UV irradiation to the protective tanning p53 response

Journal of Pathology

Volumn 190, Issue 1, 2000, Pages 39-46

  Nylander, Karin ^a,b   Bourdon, Jean Christophe ^c   Bray, Susan E ^a   Gibbs, Neil K ^a   Kay, Richard ^a   Hart, Ian ^d   Hall, Peter A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d G   (United Kingdom)

Author keywords

DNA damage; Melanogenesis; p53; Promoter; TRP 1; Tyrosinase; UV light

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; PROTEIN P53; TYROSINASE RELATED PROTEIN 1;

ARTICLE; DNA DAMAGE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MELANOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN COLOR; SKIN PIGMENTATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

BASE SEQUENCE; BINDING SITES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MELANINS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEINS; SKIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0033958912     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200001)190:1<39::AID-PATH492>3.0.CO;2-V     Document Type: Article

References (52)

1. Menon IA, Haberman HF. Mechanisms of action of melanins. Br J Dermatol 1977; 97: 109-112.
2. Kaidbey KH, Poh Agrin P, Sayre RM, Kligman AM. Photo-protection by melanin - a comparison of black and Caucasian skin. J Am Acad Dermatol 1979; 1: 249-260.
3. Valverde P, Manning P, Todd C, McNeil CJ, Thody AJ. Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion. Exp Dermatol 1996; 5: 247-253.
4. Okoro AN. Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92: 485-492.
5. Fitzpatrick TB, Szabó G, Wick MM. Biochemistry and physiology of melanin pigmentation. In Biochemistry and Physiology of the Skin, Goldsmith LA (ed.). Oxford University Press: New York, 1983; 687-708.
6. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991; 5: 2902-2909.
7. Kobayashi T, Vieira WD, Potterf B, Sakai C, Imokawa G, Hearing VJ. Modulation of melanogenic protein expression during the switch from eu-to pheomelanogenesis. J Cell Sci 1995; 108: 2301-2309.
8. Kobayashi T, Urabe K, Winder A, et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994; 13: 5818-5825.
9. Winder A, Kobayashi T, Tsukamoto K, et al. The tyrosinase gene family - interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 1994; 40: 613-626.
10. Jimbow K, Gomez PF, Toyofuku K, et al. Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study. Pigment Cell Res 1997; 10: 206-213.
11. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187: 112-126.
12. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.
13. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995; 9: 600-611.
14. Nikiforov MA, Hagen K, Ossovskaya VS, et al. p53 modulation of anchorage independent growth and experimental metastasis. Oncogene 1996; 13: 1709-1719.
15. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996; 10: 934-947.
16. Lowe SW, Ruley HE. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 1993; 7: 535-545.
17. Sakaguchi K, Herrera JE, Saito S, et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998; 12: 2831-2841.
18. Giaccia AM, Kastan MB. Genes Dev 1998; 12: 2973-2983.
19. Lane DP, Hall PA. MDM2 - arbiter of p53's destruction. Trends Biochem Sci 1997; 22: 372-374.
20. Bourdon JC, Deguin-Chambon V, Lelong JC, et al. Further characterisation of the p53 responsive element - identification of new candidate genes for trans-activation by p53. Oncogene 1997; 14: 85-94.
21. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nature Genet 1992; 1: 45-49.
22. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
23. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10: 1054-1072.
24. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
25. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-299.
26. Kastan MB, Zhan Q, El-Deiry WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-597.
27. Okamoto K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 1994; 13: 4816-4822.
28. Shivakumar CV, Brown DR, Deb S, Deb SP. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol 1995; 15: 6785-6793.
29. Buckbinder L, Talbott R, Velasco-Miguel S, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377: 646-649.
30. Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C. A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. EMBO J 1998; 17: 5015-5025.
31. Hermeking H, Lengauer C, Polyak K, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11.
32. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
33. Takei Y, Ishikawa S, Tokino T, Muto T, Nakamura Y. Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system. Genes Chromosomes Cancer 1998; 23: 1-9.
34. Israeli D, Tessler E, Haupt Y, et al. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J 1997; 16: 4384-4392.
35. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-207.
36. Eller MS, Yaar M, Gilchrest BA. DNA damage and melanogenesis. Nature 1994; 372: 413-414.
37. Eller MS, Ostrom K, Gilchrest BA. DNA damage enhances melanogenesis. Proc Natl Acad Sci U S A 1996; 93: 1087-1092.
38. Gilchrest BA, Park H-Y, Eller MS, Yaar M. Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 1996; 63: 1-10.
39. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967.
40. Hupp TR, Lane DP. Allosteric activation of latent p53 tetramers. Curr Biol 1994; 4: 865-875.
41. Hupp TR, Lane DP. Two distinct signalling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J Biol Chem 1995; 270: 18165-18174.
42. Funk WD, Pak DT, Karas RH, Wright WE, Shay JW. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 1992; 12: 2866-2871.
43. Kichina J, Green A, Rauth S. Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines. Pigment Cell Res 1996; 9: 85-91.
44. Ludwig RL, Bates S, Vousden KH. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol 1996; 16: 4952-4960.
45. Lassus P, Ferlin M, Piette J, Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J 1996; 15: 4566-4573.
46. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996; 10: 2438-2451.
47. Kroiss MM, Bosserhoff AK, Vogt T, et al. Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas. Melanoma Res 1998; 8: 504-509.
48. Tsao H, Zhang X, Majewski P, Haluska FG. Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res 1999; 59: 172-174.
49. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP, Hall PA. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995; 108: 1843-1848.
50. MacCallum DE, Hupp TR, Midgley CA, et al. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 1996; 13: 2575-2587.
51. Tief K, Schmidt A, Beermann F. New evidence for presence of tyrosinase in substantia nigra, forebrain and midbrain. Brain Res Mol Brain Res 1998; 53: 307-310.
52. Hall PA, Meek D, Lane DP. p53 - integrating the complexity. J Pathol 1996; 180: 1-5.